Clinically reviewed by Dr. Sarah Boss, MD
Slow or difficult breathing, collapse, a seizure or inability to wake someone requires emergency help. Do not combine benzodiazepines, calculate your own dose conversion or abruptly stop regular treatment.
Diazepam and lorazepam are benzodiazepines, but sharing a medicine class does not make them interchangeable. Their duration, licensed uses and handling by the body differ. Both can reduce distress in selected circumstances, and both require attention to sedation, physical dependence and withdrawal. A useful comparison starts with why the medicine was prescribed, how it is actually being taken and what the next stage of care should achieve.
What the medicines have in common
Both medicines enhance inhibitory signaling involving gamma-aminobutyric acid, usually shortened to GABA. They can produce calming, sedating and anticonvulsant effects. Those effects are not equivalent to resolving the underlying causes of anxiety, insomnia or substance-use problems. Becoming sleepy after a tablet does not by itself show that a treatment is improving everyday functioning.
The diazepam guide and lorazepam guide cover the individual medicines. Diazepam may be familiar as Valium and lorazepam as Ativan, although brands and products vary. The active ingredient, formulation and prescription instructions are more reliable identifiers than a tablet’s appearance. [1] [2]
Clinical uses are not identical
Diazepam has uses involving severe anxiety, muscle spasm, seizures and procedural sedation. It also has a role in selected medically managed alcohol-withdrawal plans. Lorazepam is used for severe anxiety, associated sleeping difficulties and pre-procedure medication; injectable lorazepam has hospital uses, including treatment of seizures. Which indications apply depends on the country and the actual formulation. [3]
A prescription for one circumstance should not be repurposed for another. Tablets left after a procedure are not an independent treatment plan for panic attacks or alcohol withdrawal. Equally, an emergency injection given in hospital does not establish that the same medicine should be taken routinely at home. Ask the prescriber to state the specific target and intended duration.
Duration and accumulation
Diazepam is longer acting and has active metabolites that can extend its effects. With repeated use, it can accumulate. Lorazepam is generally shorter acting than diazepam. This difference can influence daytime impairment, the timing of symptoms between doses and how a clinician approaches a treatment change. It does not mean lorazepam is automatically safer or that diazepam prevents withdrawal. [3]
Several different questions are often compressed into the word duration: when a person first notices an effect, how long they feel sleepy, and how long the medicine remains pharmacologically relevant. These are not the same measurement. Avoid deciding when it is safe to drive, drink alcohol or take another sedative from a single online half-life figure.
Why milligram comparisons mislead
The number printed on a tablet is not a measure of overall clinical strength across different medicines. Benzodiazepine equivalence estimates are approximate and must account for individual response, indication and organ function. A lower-numbered lorazepam tablet is not necessarily a milder treatment than a higher-numbered diazepam tablet. [3]
This guide deliberately provides no conversion table. Bring the packaging and an accurate record of actual use to a review. Include any additional tablets taken during difficult periods, even when that feels uncomfortable to discuss. The clinician needs the true exposure to assess risk; an idealized account of the prescription can lead to an unsuitable plan.
Mental health treatment and longer-term support
For anxiety-related prescribing, discuss whether the intended benefit is short-term crisis relief, sleep during an acute episode or another defined goal. NHS guidance generally describes brief courses for anxiety and sleep problems. Continuing beyond an initial course requires a fresh discussion of benefit, harms and alternatives rather than automatic renewal. Specialist exceptions should be explained individually. [4]
Useful outcomes include managing appointments, working safely, sleeping without excessive daytime impairment and participating in therapy. A treatment that reduces one symptom but leaves someone too sedated to function needs reassessment. Psychological treatment, treatment of co-occurring depression and practical support may be important parts of the wider plan.
Alcohol withdrawal is a separate clinical task
Benzodiazepines can be used within alcohol-withdrawal treatment, but the choice and setting depend on clinical assessment. Physical health, previous severe withdrawal, other medicines and available monitoring matter. Neither a diazepam nor a lorazepam prescription makes it safe to improvise a home detox. Severe alcohol withdrawal can require emergency or hospital care.
The important comparison is not simply which tablet produces more relaxation. It is whether the service can assess the person, recognize deterioration, monitor treatment and arrange continuing care. Read the alcohol withdrawal guide alongside any medicine-specific information. Treatment of acute withdrawal is also different from ongoing treatment for alcohol use disorder.
Liver health, age and other vulnerabilities
Longer-acting benzodiazepines can accumulate particularly problematically in liver impairment. Lorazepam has a different metabolic profile, but this does not make it unrestricted in liver disease. Specialist Pharmacy Service advises product-specific assessment rather than assuming a routine switch to diazepam suits everyone. Older adults and people with kidney impairment may also be more sensitive to adverse effects. [3]
Report falls, confusion, breathing disorders and difficulty waking in the morning. Pregnancy, breastfeeding and plans to conceive also belong in the review. These details may affect the choice, monitoring or treatment setting; they should not trigger an abrupt independent stop in someone taking regular medication.
Side effects and everyday safety
Sleepiness, impaired coordination and problems with memory or concentration can affect both treatments. Some people have unexpected behavioral reactions rather than straightforward calming. Tell the clinician about new agitation, disinhibition or a marked change in behavior. Record when the problem began and whether another medicine, illness or substance-use change occurred at the same time. [1] [2]
Do not drive or operate dangerous machinery while impaired. Being accustomed to the sensation does not reliably establish that coordination and judgment are normal. The sedation and driving guide provides practical questions for discussing work, travel and daily responsibilities.
Interactions and overdose warning signs
Alcohol, opioids and other sedating medicines can magnify breathing and sedation risks. Include sleep medicines, sedating antihistamines, gabapentinoids and non-prescribed substances in the medication list. FDA benzodiazepine warnings emphasize misuse, addiction, dependence and potentially serious reactions with other substances. [5]
Slow or difficult breathing, collapse or inability to wake someone requires emergency help, not an admissions inquiry. A seizure or severe confusion after an interruption also needs urgent assessment. Do not give extra sedatives to manage an unexplained deterioration. Tell emergency clinicians what was taken and when, including any alcohol or opioid exposure.
Dependence, tolerance and addiction
Physical dependence means the body has adapted and may react to a reduction or missed doses. Addiction involves additional features such as impaired control or continued use despite harm. Neither should be diagnosed solely from the presence of a prescription. Tolerance, where an effect diminishes over time, is another reason to review treatment rather than independently increase it.
The MHRA strengthened information about these risks in January 2026. Problems can occur during prescribed use, and discussions should be nonjudgmental. A history of substance-use problems makes careful assessment especially important, but should not prevent someone from receiving appropriate help. [6]
Stopping and switching
Regular benzodiazepine treatment should not usually be stopped abruptly. Withdrawal can include anxiety, insomnia and physical symptoms and can become dangerous. NICE recommends an individualized, flexible plan that considers duration of use, prior withdrawal and other medicines. Switching to a longer-acting medicine is a clinical option in some circumstances, not a requirement for every patient. [7]
Agree who will provide prescriptions, how symptoms will be reviewed and what to do if the plan becomes difficult. A move between countries or services should not create an unplanned interruption. The benzodiazepine withdrawal guide explains why assessment and ongoing support matter.
Questions for the next appointment
Ask which benefit justifies continuing, whether the original goal still applies, and which effects deserve monitoring. Clarify why this particular benzodiazepine was selected, whether another clinician is prescribing a sedative, and what would prompt a change. A written plan should distinguish routine questions from emergencies and name the person responsible for follow-up.
A practical plan for treatment transitions
Before a hospital stay, residential admission or change of prescriber, write down the actual benzodiazepine regimen and the reason it was started. Include occasional use as well as regular tablets. Ask the receiving service to confirm what it can prescribe and how it will obtain information from the current clinician. Do not assume that a medicine available in one country will be supplied under the same name elsewhere.
A handover should distinguish the established prescription from any proposed change. It should say who authorized the plan, who will monitor symptoms and how urgent advice can be obtained. This is particularly important when someone also receives opioid pain treatment or another sedative from a separate service. The patient should not be left to resolve conflicting instructions by choosing whichever prescription feels more reassuring.
At follow-up, compare the original goal with the current experience. Ask whether daytime functioning has improved, whether memory or falls have become concerns and whether the person still understands the intended duration. Record the agreed next step in plain language. A review is useful even when the decision is to maintain treatment temporarily while another part of care is arranged. It should reduce uncertainty rather than force a hurried change solely because a previous course has lasted longer than expected.
Frequently asked questions
Is lorazepam stronger than diazepam?
Potency per milligram differs, but stronger is not the same as more appropriate. The clinical comparison includes indication, formulation, duration, response and vulnerability to adverse effects. Do not calculate a personal substitution from tablet numbers.
Is diazepam always easier to stop?
No. Its longer action can influence a withdrawal plan, but individual history and health remain important. Accumulation can also create problems. A clinician should explain the reasons for any proposed switch.
Can the medicines be taken together?
Do not add one to the other independently. Any overlap must be specifically directed and monitored by the treating clinician, with the complete medicine and substance-use history available.
Evidence and sources
- [1] NHS: Diazepam.
- [2] NHS: About lorazepam.
- [3] NHS Specialist Pharmacy Service: Oral benzodiazepines and choosing equivalent doses.
- [4] NHS: How and when to take lorazepam.
- [5] FDA: Updated boxed warnings for benzodiazepines.
- [6] MHRA: Strengthened dependence and addiction warnings, January 2026.
- [7] NICE NG215: Safe prescribing and withdrawal management.


